Atlas Trials

Phase 3 Immunogenicity and Safety Study of an Inactivated H5N1 Influenza Vaccine (Whole Virion, Vero Cell Derived)

Clinical trial NCT00462215 · COMPLETED

Trial details

NCT number
NCT00462215
Sponsor
Alachua Government Services, Inc.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Influenza
Start date
2007-04-01
Primary completion
2007-06-01
Enrollment
550

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.